THC Farmaceuticals, Inc (CBDG) financial statements (2021 and earlier)

Company profile

Business Address 7170 E. MCDONALD DRIVE
SCOTTSDALE, AZ 85253
State of Incorp. UT
Fiscal Year End September 30
SIC 6199 - Finance Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

6/30/2015
Q3
3/31/2015
Q2
12/31/2014
Q1
9/30/2014
Q4
6/30/2014
Q3
3/31/2014
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments65863121
Cash and cash equivalents65863121
Receivables123212
Other undisclosed current assets2512(0)   
Total current assets:325996233
Noncurrent Assets
Property, plant and equipment121212121212
Long-term investments and receivables83750    
Long-term investments83750    
Intangible assets, net (including goodwill)2551,04234343434
Intangible assets, net (excluding goodwill)2551,04234343434
Other undisclosed noncurrent assets579     
Total noncurrent assets:1,6831,10446464646
TOTAL ASSETS:1,7151,70352484949
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1631351 
Accounts payable1631351 
Due to related parties 650211 
Other undisclosed current liabilities  (2)  1
Total current liabilities:1665313621
Noncurrent Liabilities
Liabilities, other than long-term debt684 57877 
Due to related parties684 57877 
Other undisclosed noncurrent liabilities10 121183
Total noncurrent liabilities:68505908783
Total liabilities:70165418968984
Stockholders' equity
Stockholders' equity attributable to parent1,0141,05034(48)(39)(35)
Common stock15159999
Additional paid in capital1,2031,203184848484
Accumulated deficit(204)(168)(159)(141)(132)(128)
Total stockholders' equity:1,0141,05034(48)(39)(35)
TOTAL LIABILITIES AND EQUITY:1,7151,70352484949

Income statement (P&L) ($ in thousands)

6/30/2015
Q3
3/31/2015
Q2
12/31/2014
Q1
9/30/2014
Q4
6/30/2014
Q3
3/31/2014
Q2
Gross profit:554545
Operating expenses(40)(24)(13)(12)(7)(7)
Other undisclosed operating income (loss)(0)0    
Operating loss:(35)(20)(9)(7)(2)(2)
Interest and debt expense(0)(0)  (2)(0)
Loss from continuing operations before income taxes:(36)(20)(9)(7)(4)(2)
Other undisclosed income from continuing operations   6  
Net loss:(36)(20)(9)(1)(4)(2)
Other undisclosed net income (loss) attributable to parent0  (8) (2)
Net loss available to common stockholders, diluted:(36)(20)(9)(9)(4)(4)

Comprehensive Income ($ in thousands)

6/30/2015
Q3
3/31/2015
Q2
12/31/2014
Q1
9/30/2014
Q4
6/30/2014
Q3
3/31/2014
Q2
Net loss:(36)(20)(9)(1)(4)(2)
Comprehensive loss, net of tax, attributable to parent:(36)(20)(9)(1)(4)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: